Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.

Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Abstract Text:

    takafumi ichikawaTakafumi Ichikawa,hiroyoshi otaHiroyoshi Ota,atsushi sugiyamaAtsushi Sugiyama,fukuto marutaFukuto Maruta,tomoaki ikezawaTomoaki Ikezawa,kyoko hottaKyoko Hotta,kazuhiko ishiharaKazuhiko Ishihara,takafumi ichikawaTakafumi Ichikawa,hiroyoshi otaHiroyoshi Ota,atsushi sugiyamaAtsushi Sugiyama,fukuto marutaFukuto Maruta,tomoaki ikezawaTomoaki Ikezawa,kyoko hottaKyoko Hotta,kazuhiko ishiharaKazuhiko Ishihara,

    BACKGROUND AND AIM: Lafutidine is a novel histamine H(2)-receptor antagonist used primarily as an antisecretory agent in Japan. Previous human studies have not assessed its gastroprotective effects. The purpose of the present study was to determine the effects of lafutidine on the human gastric mucus layer using both histological and biochemical methods. METHODS: Of the 14 patients scheduled for gastrectomy who consented to participate, seven were given 14 days of lafutidine 20 mg/day (lafutidine group) and the others received no medication (control group). The surface mucus gel layer in Carnoy-fixed tissue sections was examined immunohistochemically. Both the thickness of the mucus layer and its mucin content were measured in gastric corpus mucosa. RESULTS: There was no detectable difference between the groups in the grade of gastritis or the immunohistochemical staining characteristics. The laminated structure of the surface mucus gel layer was retained after administration of lafutidine and it was thicker than the layer in the control group. The surface layer in the lafutidine group had three-fold more mucin than that in the control group. There was no difference between the two groups in the mucin content of the deep mucosa. CONCLUSION: Lafutidine, given at clinical dosages, not only inhibits acid secretion but also strengthens the mucus barrier of the human gastric mucosa.

    Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Publishing Authors By Initials

    t ichikawaT Ichikawa,h otaH Ota,a sugiyamaA Sugiyama,f marutaF Maruta,t ikezawaT Ikezawa,k hottaK Hotta,k ishiharaK Ishihara,t ichikawaT Ichikawa,h otaH Ota,a sugiyamaA Sugiyama,f marutaF Maruta,t ikezawaT Ikezawa,k hottaK Hotta,k ishiharaK Ishihara,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of gastroenterology and hepatology

    VOLUME: 22

    Page Numbers: 1800-5

    Journal Abbreviation: J. Gastroenterol. Hepatol.

    ISSN: 0815-9319

    DAY: 4

    MONTH: Nov

    YEAR: 2007

    Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8607909

    Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.

    AFFILIATION: Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan. t.ichika@kitasato-u.ac.jp

    Country: Australia

    Australia Research PublicationAustralia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Gastroenterol Hepatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News